Bluejay Diagnostics (BJDX) Interest Expenses (2020 - 2026)
Bluejay Diagnostics (BJDX) reported Interest Expenses of $100000.0 for Q1 2026, up 161.38% on a YoY basis from $38259.0 in Q1 2025, and up 53375.94% sequentially from $187.0 in Q4 2025.
Bluejay Diagnostics (BJDX) Interest Expenses (2020 - 2026) Analysis & Trends
Bluejay Diagnostics (BJDX) has 7 years of Interest Expenses data on file, last reported at $100000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 161.38% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $100000.0 (down 93.46% YoY), and the FY2025 full-year result was $12.1 million, up 20.47% from the prior year.
- Interest Expenses rose to $100000.0 in Q1 2026, from $187.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $674155.0 in Q4 2024 to a low of $187.0 in Q4 2025.
- A 5-year average of $128781.9 and a median of $43948.0 in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses jumped 3607.64% in 2024 and slumped 99.97% in 2025, its largest moves.
- Tracing BJDX's Interest Expenses over 5 years: stood at $36617.0 in 2022, then climbed by 20.02% to $43948.0 in 2023, then surged by 1433.98% to $674155.0 in 2024, then tumbled by 99.97% to $187.0 in 2025, then surged by 53375.94% to $100000.0 in 2026.
- Business Quant data shows BJDX's Interest Expenses at $100000.0 in Q1 2026, $187.0 in Q4 2025, and $7008.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 400.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -97.17 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 96.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | -140.00 Mn |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 187.00 |
| Dec 31, 2025 | 187.00 |
| Sep 30, 2025 | 7,008.00 |
| Sep 30, 2025 | 7,008.00 |
| Jun 30, 2025 | 9,623.00 |
| Jun 30, 2025 | 9,623.00 |
| Mar 31, 2025 | 38,259.00 |
| Mar 31, 2025 | 38,259.00 |
| Dec 31, 2024 | 674,155.00 |
| Dec 31, 2024 | 674,155.00 |
| Sep 30, 2024 | 190,610.00 |
| Sep 30, 2024 | 190,610.00 |
| Jun 30, 2024 | 626,471.00 |
| Jun 30, 2024 | 626,471.00 |
| Mar 31, 2024 | 44,214.00 |
| Mar 31, 2024 | 44,214.00 |
| Dec 31, 2023 | 43,948.00 |
| Dec 31, 2023 | 43,948.00 |